CXCL5 impedes CD8⁺ T cell immunity by upregulating PD-L1 expression in lung cancer via PXN/AKT signaling phosphorylation and neutrophil chemotaxis.

Autor: Sun, Dantong¹ (AUTHOR), Tan, Lipin² (AUTHOR), Chen, Yongbing¹ (AUTHOR), Yuan, Qiang³ (AUTHOR), Jiang, Kanqiu¹ (AUTHOR), Liu, Yangyang⁴ (AUTHOR), Xue, Yuhang⁵ (AUTHOR), Zhang, Jinzhi¹ (AUTHOR), Cao, Xianbao¹ (AUTHOR), Xu, Minzhao¹ (AUTHOR), Luo, Yang¹ (AUTHOR), Xu, Zhonghua¹ (AUTHOR), Xu, Zhonghen¹ (AUTHOR), Xu, Weihua¹ (AUTHOR), Shen, Mingjing¹ (AUTHOR) shenmingjing0707@126.com

Publikováno v: Journal of Experimental & Clinical Cancer Research (17569966). 7/22/2024, Vol. 43 Issue 1, p1-15. 15p.

Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy.

Autor: Sun, Dantong^1,2 (AUTHOR), Qian, Haili² (AUTHOR) qianhaili001@163.com, Li, Junling¹ (AUTHOR) lijunling@cicams.ac.cn, Xing, Puyuan¹ (AUTHOR) xingpuyuan@cicams.ac.cn

Publikováno v: Journal of Biomedical Science. 1/29/2024, Vol. 31 Issue 1, p1-12. 12p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Next-generation sequencing identifies potential novel therapeutic targets in Chinese HGSOC patients

Autor: Tao, Junyan, Sun, Dantong, Zhou, Hai, Zhu, Jingjuan, Zhang, Xiaochun, Hou, Helei

Publikováno v: In Pathology - Research and Practice October 2022 238

Multiomics analysis revealed the mechanisms related to the enhancement of proliferation, metastasis and EGFR-TKI resistance in EGFR-mutant LUAD with ARID1A deficiency.

Autor: Sun, Dantong^1,2 (AUTHOR), Feng, Feiyue³ (AUTHOR), Teng, Fei¹ (AUTHOR), Xie, Tongji¹ (AUTHOR), Wang, Jinsong² (AUTHOR), Xing, Puyuan¹ (AUTHOR) xingpuyuan@cicams.ac.cn, Qian, Haili² (AUTHOR) qianhaili001@163.com, Li, Junling¹ (AUTHOR) lijunling@cicams.ac.cn

Publikováno v: Cell Communication & Signaling. 3/3/2023, Vol. 21 Issue 1, p1-16. 16p.